AutismKB: an evidence-based knowledgebase of autism genetics by Xu, Li-Ming et al.
AutismKB: an evidence-based knowledgebase
of autism genetics
Li-Ming Xu, Jia-Rui Li, Yue Huang, Min Zhao, Xing Tang and Liping Wei*
Center for Bioinformatics, State Key Laboratory of Protein and Plant Gene Research, College of Life Sciences,
Peking University, Beijing, 100871, P.R. China
Received August 14, 2011; Revised October 4, 2011; Accepted November 9, 2011
ABSTRACT
Autism spectrum disorder (ASD) is a heterogeneous
neurodevelopmental disorder with a prevalence
of 0.9–2.6%. Twin studies showed a heritability of
38–90%, indicating strong genetic contributions.
Yet it is unclear how many genes have been
associated with ASD and how strong the evidence
is. A comprehensive review and analysis of literature
and data may bring a clearer big picture of autism
genetics. We show that as many as 2193 genes,
2806 SNPs/VNTRs, 4544 copy number variations
(CNVs) and 158 linkage regions have been asso-
ciated with ASD by GWAS, genome-wide CNV
studies, linkage analyses, low-scale genetic associ-
ation studies, expression profiling and other
low-scale experimental studies. To evaluate the
evidence, we collected metadata about each study
including clinical and demographic features, experi-
mental design and statistical significance, and used
a scoring and ranking approach to select a core
data set of 434 high-confidence genes. The genes
mapped to pathways including neuroactive ligand–
receptor interaction, synapse transmission and
axon guidance. To better understand the genes we
parsed over 30 databases to retrieve extensive data
about expression patterns, protein interactions,
animal models and pharmacogenetics. We con-
structed a MySQL-based online database and
share it with the broader autism research
community at http://autismkb.cbi.pku.edu.cn, sup-
porting sophisticated browsing and searching
functionalities.
INTRODUCTION
Autism spectrum disorder (ASD) is a heterogeneous
neurodevelopmental disorder characterized by impair-
ments in reciprocal social interaction and communication
and presence of restricted, repetitive and stereotyped
patterns of behavior, interests and activities (1). ASD is
an umbrella term for Autistic Disorder, Asperger
Syndrome and Pervasive Developmental Disorder Not
Otherwise Speciﬁed (PDD-NOS) (1). With an early
onset prior to age 3 and a prevalence as high as
0.9–2.6% (2,3), ASD is one of the leading causes of child-
hood disability and inﬂicts serious suffering and burden
for the family and society (4).
Understanding the causes of ASD is critical for develop-
ing better treatment. Twin studies have shown that the
heritability of ASD is as high as 38–90%, indicating
strong contributions by genetic factors as well as environ-
mental factors (5,6). The search for environmental factors
has not yet led to convincing major candidates whereas
the search for genes associated with autism, although far
from complete or conclusive, has been more fruitful. The
genes discovered so far can be roughly grouped into two
categories: ‘syndromic autism related genes’ or causal
genes underlying genetic disorders that cause autistic
symptoms such as Fragile X Syndrome, Rett Syndrome,
Tuberous Sclerosis Complex and dozens of other dis-
orders (7,8), and ‘non-syndromic autism related genes’
most of which are susceptibility genes (9). Many experi-
mental methods have been used to identify associated
genes, including the earlier linkage analyses and low-
scale candidate gene association or experimental studies
as well as the more recent genome-wide association
studies (GWAS), genome-wide CNV studies and expres-
sion proﬁling.
With hundreds of studies published, especially the
recent genome-wide studies, and with the next-generation
sequencing technologies providing even more power for
further gene discoveries (10), a new challenge has
emerged: it has become more and more difﬁcult for an
autism researcher to answer with conﬁdence how many
genes have been associated with ASD, how strong the
evidence is, what features the genes have and what
pathways they involve. The amount of available literature
and data and the intrinsic complexity of autism genetics
demand bioinformatic data management and analysis.
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collect genes and variations associated with ASD: AutDB
(also known as SAFRI Gene) collected 219 genes (11,12),
Autism genetic database (AGD) collected 226 genes and
743 CNVs (13) and Autism Chromosome Rearrangement
Database (ACRD) collected 372 breakpoints and other
genomic features (14). However, they are far from a com-
prehensive survey of autism genetics. To bring a clearer
big picture of autism genetics, we performed a comprehen-
sive review and analysis of published literature and data,
described below, resulting in a total of 2193 genes, 2806
SNPs/VNTRs, 4544 CNVs and 158 linkage regions. We
provide the results as an online resource for the broader
autism research community at http://autismkb.cbi.pku
.edu.cn/ with extensive evidence and annotations, support-
ing sophisticated browsing and searching functionalities.
DATA COLLECTION
Literature search
We searched the PubMed database for publications
related to autism genetics, using the query term ‘autism
AND associat*’ for association studies, ‘autism AND
(gene OR microarray OR proteomics)’ for expression
proﬁling studies and the other low-scale experimental
studies, and ‘autism AND (CNV OR copy number vari-
ation OR microarray* OR microdel* OR microdup* OR
rearrange* OR (genome-wide AND (linkage OR associa*
OR scan)))’ for CNV and linkage studies. The abstracts
of the 4000+ articles retrieved were reviewed to remove
irrelevant papers, resulting in a ﬁnal set of 579 articles,
reporting a total of 11 GWAS, 242 low-scale candidate
gene association studies, 13 expression proﬁling studies,
95 genome-wide CNV studies, 23 genome-wide linkage
analyses and 236 other low-scale experimental studies.
For syndromic autism-related genes, we ﬁrst collected
the autism-related disorders and their causal genes from
a recently published comprehensive review (7). We then
searched OMIM to get the ofﬁcial disease names
and linked all the disorders to OMIM, and searched
PubMed for additional citations using the query
‘(OMIM disease name) AND autism’ for each disease.
All citations were double-checked manually. Finally, 99
genes for 94 autism-related disorders supported by 250
references were included in our data set of ‘Syndromic
Autism Related Genes’.
In total, we collected as many as 2135 non-syndromic
autism-related genes, 99 syndromic autism-related genes,
4544 CNVs and 158 linkage regions. The genes located in
the CNV and linkage regions were then retrieved by the
UCSC Genome Browser (15).
Evidence collection
To establish the strength of evidence, we collected
metadata about each study and result. Supplementary
Table S1–S7 list the evidence collected for each type
of experimental methods. In summary, for each study of
non-syndromic autism, we collected the clinical and demo-
graphic features of the samples including ancestral back-
ground, country of origin, inclusion and exclusion criteria,
number of cases and controls with gender ratio, age at
examination and diagnosis criteria. We collected metadata
about the experimental design including platform,
experimental methods, statistical methods and statistical
signiﬁcance.
For each gene, we estimated how much evidence
supports its role in autism by each type of experimental
methods and calculated a weighted sum, following a
multi-dimensional evidence-based candidate gene priori-
tization approach (16). First, we assigned initial scores
to the genes for each type of experimental methods
(Supplementary Table S8). Score 0 is given if there is no
positive evidence of the type. Table 1 lists the distribution
of the scores for each type. Next, we used a benchmark
data set consisting of 21 non-syndromic autism-related
genes considered high conﬁdence from six autism
reviews (8,9,17–20)( Supplementary Table S9) to calculate
the weights. We followed a gene prioritization approach
(16) to generate a candidate weight matrix pool consisting
of d
N=7
6 weight vectors, where N represents the number
of experimental methods and d=N+1 represents possible
different weights, 1–7 in the weight vectors. A combined
score for each gene was then calculated by summing up
the products of the scores and corresponding weights from
the six experimental methods (16). All the 2135 candidate
genes including 21 benchmark genes were sorted by their
combined scores. We selected the weight matrix that gave
the benchmark genes the highest rank as the optimal
weight matrix (Supplementary Table S10). About 95%
benchmark genes were ranked among the top 98% of all
candidate genes. We chose the lowest combined score, 9,
from the benchmark data set as the cutoff of high-
conﬁdent genes, resulting in a core data set of 383 non-
syndromic autism-related genes. Because the deﬁnition of
‘optimal weight matrix’ is always debatable, we provide an
online ranking tool to allow users to re-rank the genes
interactively by inputting customized weights based on
their own experiences and preferences.
Table 1. Score distribution of genes discovered by each experiment
method
Experimental
methods
Scores Number
of Genes
Genome-wide association studies 1 81
24 6
35
Expression proﬁling 1 1320
2 285
35 0
Genome-wide CNV studies 1 1086
23 4
31 9
Linkage analyses 1 535
24 3
30
Low scale genetic association studies 1 128
22 3
31 2
Other low-scale experimental studies 1 241
23 7
33 0
Nucleic Acids Research, 2012,Vol. 40,Database issue D1017For syndromic autism, we assigned four levels to the
autism-related disorders: Level 1 disorders have one
reported case with autistic symptoms, Level 2 have two
to three cases in a single family, Level 3 have cases in more
than one family and Level 4 are reported in multiple
review papers (8). Causal genes of Level 3 and 4 disorders
were considered high-conﬁdent genes in the core dataset.
Functional annotations
To better understand the function of the genes associated
with autism, we collected extensive functional information
and data, including crosslinks to NCBI Entrez gene (21),
OMIM (21), Uniprot (http://www.uniprot.org/) and
Ensembl (http://www.ensembl.org/), functional groups
based on Gene Ontology (http://www.geneontology.org/),
protein–protein interactions from database BioGRID
(22), BIND (23) and HPRD (24), and genomic variants
from the Database of Genomic Variants (DGV) (25).
We linked the genes to three psychiatric disease databases,
AlzGene (26), SzGene (27) and PDGene (http://www
.pdgene.org/), when the gene is common between these
diseases and ASD. Information about homologues of
the genes were retrieved from Mouse Genome
Informatics (MGI) (28), Zebraﬁsh Model Organism
Database (ZFIN) (29) and FlyBase (30). We collected
comprehensive mRNA expression proﬁling data,
including ESTs from NCBI Unigene Proﬁles (21), micro-
array expression proﬁles from BioGPS (31) and Allen
Brain Atlas (32), and RNA-Seq (33–38). Protein expres-
sion evidence at peptide level was retrieved from PRIDE
(39) and Peptide Atlas (40). We also collected transcrip-
tion factor binding sites in the upstream regions of the
genes from in-house collection of ChIP-Chip and
ChIP-Seq data, miRNAs that may target the genes from
miRWalk (41) and TarBase (42), and natural antisense
transcripts that may regulate the genes from NATsDB
(43). Possible post-translation modiﬁcations were
retrieved from UniProt and dbPTM (44). We used
KOBAS 2.0 (45) to retrieve the pathways that the genes
are involved in from BioCyc (46), KEGG Pathway (47),
PID (48), PID Reactome (48), PANTHER (49) and
Reactome (50) and possible association with other
diseases from Disease databases include KEGG Disease
(51), FunDO (52,53), GAD (54), NHGRI GWAS Catalog
(55) and OMIM (21). Pharmaco-genetics and drug infor-
mation was collected from Comparative Toxicogenomics
Database (CTD) (56), Pharmacogenomics Knowledge
Base (57) and DrugBank (58). Supplementary Table S11
summarizes the gene coverage from each source database.
The overlap between the genes discovered by expression
proﬁling and those by the other genetic technologies is
shown in Supplementary Table S12.
Enriched functional pathways were identiﬁed by
KOBAS 2.0 (45) and enriched GO terms were identiﬁed
by DAVID (59). Pathways such as neuroactive ligand–
receptor interaction, synapse transmission, and axon
guidance were statistically signiﬁcantly enriched in the
core data set (Table 2). In addition to synapse transmis-
sion, GO terms such as transmission of nerve impulse,
neuron differentiation were also found to be statistically
signiﬁcant (Table 3). The result is consistent with recent
ﬁndings that synapse development, axon targeting and
neuron motility are related to autism etiology (60,61).
DATABASE INTERFACE
We set up a MySQL relational database to store all the
data. A user-friendly web interface for browsing and
searching was implemented by PHP and JavaScript,
powered by JQuery framework.
Table 3. Top 10 enriched GO terms of the genes in the high-conﬁdent core dataset
GO ID GO Term P Value Q Value
GO:0019226 transmission of nerve impulse 5.44E-29 9.73E-26
GO:0007268 synaptic transmission 4.59E-28 8.21E-25
GO:0007610 synapse 1.05E-23 1.45E-20
GO:0045202 behavior 4.53E-23 8.10E-20
GO:0044057 synapse part 7.21E-22 9.94E-19
GO:0007267 regulation of system process 4.12E-21 7.38E-18
GO:0044456 cell-cell signaling 4.17E-21 7.46E-18
GO:0030182 neuron differentiation 8.21E-19 1.47E-15
GO:0031644 regulation of neurological system process 1.53E-18 2.74E-15
GO:0051969 regulation of transmission of nerve impulse 1.74E-18 3.11E-15
Table 2. Top ﬁve enriched pathway of the genes in the high-conﬁdent core dataset, using KOBAS2.0
Term Database ID P Value Q Value
Neuroactive ligand-receptor interaction KEGG PATHWAY hsa04080 1.03E-11 1.65E-09
Synaptic Transmission Reactome REACT:13685 7.50E-10 9.06E-08
Axon guidance Reactome REACT:18266 1.29E-08 1.24E-06
Calcium signaling pathway KEGG PATHWAY hsa04020 2.25E-08 1.97E-06
Long-term potentiation KEGG PATHWAY hsa04720 1.76E-07 9.98E-06
D1018 Nucleic AcidsResearch, 2012,Vol. 40,Database issueFigure 1. A typical gene entry in AutismKB. (A) Basic information and quick links, (B) nucleotide and protein sequences, (C) evidence statistics and
links to different data sources, (D) example of default collapsed data source, (E) link and example of polymorphism information and (F) example of
expanded data source with hidden information.
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Users can browse the data in AutismKB in a variety of
ways, including by data sets, experimental methods or
chromosome. The gene lists include a summary of informa-
tion about the genes, hyperlinked to detailed gene evidence
and annotation pages. Figure 1 shows a typical AutismKB
gene entry. Basic information such as gene symbol, gene
name, cytoband and cross links are provided (Figure 1A).
Nucleotide sequences and protein sequences can be sent to
WebLab (62) for further analysis (Figure 1B). Summaries
of supporting evidence and category-speciﬁc scores are
provided (Figure 1C). Users can click on the hyperlinks
of the category-speciﬁc score to view different category of
evidences. The categories without any evidence are hidden
by default (Figure 1D). Users can click on ‘+’ to expand or
‘’ to collapse different categories. Detailed information
of polymorphisms for low scale association studies and
GWAS can be found by clicking on ‘detail’ in the tables
(Figure 1E). When exploring other low-scale studies and
large-scale expression studies, users can click the down
arrow in the right of the table to obtain more information
(Figure 1F). Annotations of each gene can be obtained by
clicking the label ‘view annotation’ in the top left.
CNVs are provided by a tabular view with name,
cytoband, gain or loss, number, evidence types and refer-
ence. Users can use evidence type and chromosome to
ﬁlter the table (Figure 2A). Clicking on the name can
bring the detail information of each CNV including the
samples and methods of the study, CNV region, and any
syndromic and non-syndromic autism genes in the region
(Figure 2B). Users can use chromosome to ﬁlter the
linkage regions and click on linkage name to view
detailed information.
Searching
AutismKB supports both text-based search and
sequence-based search. Users can ﬁnd a quick search
box on the top right of each page to search by gene
Figure 2. CNV list and a typical CNV entry in AutismKB. (A) the CNV list in AutismKB and (B) a typical CNV entry.
D1020 Nucleic AcidsResearch, 2012,Vol. 40,Database issuesymbol. Advanced search was provided to search genes,
CNVs, linkage regions by gene name, gene symbol, NCBI
Entrez id, Ensemble id, GO terms, UniProt ID, location,
score, method and PubMed ID. Finally, a BLAST search
against the nucleotide or protein sequences of all
AutismKB genes is also available.
CONCLUSION
AutismKB is a comprehensive knowledgebase of
autism-related genes, CNVs and linkage regions with ex-
tensive evidence and annotations. AutismKB will be
updated periodically. We hope that it can be a valuable
resource for the autism research community.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1-12.
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